Immunocore Holdings Ltd (IMCR) — Capital Reinvestment Ratio
Latest as of June 2025:
0.02x
Immunocore Holdings Ltd (IMCR) has a Capital Reinvestment Ratio of 0.02x as of June 2025, meaning it reinvests 0% of its operating cash flow ($25.96 Million) in capital expenditures ($414.00K). See Immunocore Holdings Ltd (IMCR) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.02x
Capex / Operating Cash Flow
Operating Cash Flow
$25.96 Million
USD
Capital Expenditures
$414.00K
USD
Data as of
Jun 2025
Most recent filing
Immunocore Holdings Ltd Capital Reinvestment Ratio (2023–2024)
This chart tracks Immunocore Holdings Ltd's Capital Reinvestment Ratio across 2 annual periods.
Annual Capital Reinvestment Ratio for Immunocore Holdings Ltd (2023–2024)
Year-by-year Capital Reinvestment Ratio for Immunocore Holdings Ltd from 2023 to 2024. For live market cap and broader valuation context, see Immunocore Holdings Ltd market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.20x | $26.06 Million | $5.17 Million | ▼ -89.2% |
| 2023 | 1.85x | $2.94 Million | $5.42 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow